Delek US Holdings (DK) Decrease In Right-Of-Use Assets, Lease Terminations — Quarterly & Annual

Screener

Decrease In Right-Of-Use Assets, Lease Terminations at other companies

Solid Biosciences Inc.SLDB

$0+100%

Prime MedicinePRME

$0—

Prime MedicinePRME

$0—

Peoples Bancorp of North CarolinaPEBK

-$175K+3.8%

RF IndustriesRFIL

$108K+21.3%

Theravance BiopharmaTBPH

-$314K-848%

Other financials

Income statement

Revenue$4.1B+47.8%

Gross profit$365.1M+599%

Operating income$302.4M+1,003%

Net income$169.5M+259%

EPS (diluted)$2.71+254%

Balance sheet

Cash & equivalents$628.6M+2.1%

Total debt$3.3B+2.1%

Total equity$422.7M+43.3%

Total assets$7.6B+6.8%

Cash flow

Operating cash flow$262.9M+411%

CapEx$173.8M+4.8%

Free cash flow$89.1M+178%

Valuation

Market cap$3.66B+195%

Enterprise value$6.29B+64.2%

P/E16.3×—

P/S0.3×+0.2×

Profitability

Gross margin7.1%+6.0pp

Operating margin4.8%+3.1pp

Net margin1.9%+1.0pp

FCF margin5.7%+3.6pp

Returns & leverage

Return on equity62.6%+37.7pp

Debt / equity7.7×-3.1×

Current ratio0.8×0.0×

Where this comes from

Reported directly by Delek US Holdings in its filing.

Tagged under the XBRL concept dk:DecreaseInRightOfUseAssetsLeaseTerminations.

The source filing: Delek US Holdings’s 10-K, filed February 27, 2026. Open the filing →

Filed: Feb 27, 2026, 1:03 PM EST
Fiscal year: FY2025
Accession: 0001628280-26-012664

FAQ

What is Delek US Holdings's decrease in right-of-use assets, lease terminations?: Delek US Holdings (DK) reported decrease in right-of-use assets, lease terminations of $2.7M in Q4 2025.
What does decrease in right-of-use assets, lease terminations mean?: Decrease In Right-Of-Use Assets, Lease Terminations as reported by Delek US Holdings, Inc..

Ask your AI about Delek US Holdings's decrease in right-of-use assets, lease terminations.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk